Whole B ody 18 FDG-PET a nd t he R esponse o f E sophageal Cancer t o I nduction T herapy: R esults o f a P rospective T rial
暂无分享,去创建一个
S. Larson | V. Rusch | H. Koong | M. Bains | R. Ginsberg | M. Gonen | M. Zakowski | T. Akhurst | B. Minsky | R. Downey | M. Gollub | D. Ilson | A. Turnbull
[1] F. Shishido,et al. Positron emission tomographic evaluation of radiochemotherapeutic effect on regional cerebral hemocirculation and metabolism in patients with gliomas , 2004, Journal of Neuro-Oncology.
[2] M. Schwaiger,et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] M. Schwaiger,et al. Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission Tomography , 2001, Annals of surgery.
[4] M. Iannettoni,et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] P. Dupont,et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J. Nährig,et al. Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] F. Detterbeck,et al. Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy , 1999, Cancer.
[8] M Schwaiger,et al. Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. , 1998, Blood.
[9] G. Patterson,et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. , 1997, The Annals of thoracic surgery.
[10] J. Bosset,et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. , 1997, The New England journal of medicine.
[11] F Dehdashti,et al. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. , 1997, AJR. American journal of roentgenology.
[12] T. Walsh,et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. , 1996, The New England journal of medicine.
[13] T. Hickish,et al. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] V J Lowe,et al. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. , 1995, The Annals of thoracic surgery.
[15] J. Bergh,et al. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation? , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J. Hoffman,et al. Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy , 1994, Head & neck.
[17] R L Wahl,et al. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] M. Orringer,et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] W. J. Oakes,et al. Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor , 1989, Neurology.
[20] M. Birnbaum,et al. Growth factors rapidly induce expression of the glucose transporter gene. , 1988, The Journal of biological chemistry.
[21] F Shishido,et al. Changes of cerebral blood flow, and oxygen and glucose metabolism following radiochemotherapy of gliomas: a PET study. , 1988, Journal of computer assisted tomography.
[22] P. Pairolero,et al. Ivor Lewis esophagogastrectomy for carcinoma of the esophagus: early and late functional results. , 1987, The Annals of thoracic surgery.
[23] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .